Skip to main content
. 2023 Jun 2;9(6):e16951. doi: 10.1016/j.heliyon.2023.e16951

Fig. 3.

Fig. 3

Systolic blood pressure measurements of the SHR for the non-treated control group, free aliskiren, free PLA-NP, and aliskiren-PLA-NP treated group [32]. Reprinted from Ref. [32] with the permission of the publisher.